Key result
Inflammatory bowel disease links to elevated risk of thrombosis, including spontaneous ventricular thrombi.
Highlights the increased risk of ventricular thrombosis in patients with inflammatory bowel disease and advocates for a low threshold for imaging and thromboprophylaxis during acute flare-ups.
May heighten vigilance for ventricular thrombosis in IBD flares; leaves open optimal thromboprophylaxis strategies.
Inflammatory bowel disease is closely associated with an increased risk for thrombotic events. Thrombosis mostly occurs in the extremities, lungs, and liver; but it can also occur in the ventricles of the heart. The primary goal of this article is to increase awareness of the risk for ventricular thrombosis in this patient population among healthcare professionals and, thus, appropriate prompt use of thromboprophylaxis therapy for these patients during acute flare-ups. Early diagnosis and intervention are critical for ventricular thrombosis to prevent systemic embolisation of the thrombus. Concisely, inflammatory bowel disease predisposes to the development of thrombi. A low threshold for the use of imaging studies to detect such thrombi is warranted.
No takes yet. Share an insight, caveat, or question.
Pak et al. (2017) conducted an editorial in Inflammatory bowel disease. Inflammatory bowel disease vs. General population was evaluated. Inflammatory bowel disease increases the risk of thrombotic events, including spontaneous ventricular thrombosis, highlighting the need for thromboprophylaxis and imaging during acute flare-ups.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: